Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Johns Hopkins
 More »

  • Mass Spec Provides Peek into PTMs
    Ma, Ph.D., a postdoctoral research fellow at the laboratory of Gerald W. Hart, Ph.D., at the department of biological chemistry, Johns Hopkins University School of Medicine. ...
    5-15-2013
  • Highlights from AACR
    ... An agreement between Advanced Cell Diagnostics (ACD) and The Johns Hopkins University's Sidney Kimmel Comprehensive Cancer Center centers on the use of the company's RNAscope® ...
    5-15-2013
  • Literature Review: A Step Closer to Personalized Medicine
    One of the pancreatic lines (Panc502) was isolated from the mouse and used to test the in vitro sensitivity to a drug panel containing over 3,000 drugs (Johns Hopkins drug library ...
    5-14-2013
  • Turning Off Cancer's "Master Regulator"
    The Johns Hopkins researchers hope that this "master regulator" gene may be the key to developing a new treatment for tumors resistant to current drugs. "This master regulator is ...
    5-3-2013
  • Exposing the Exposome
    ... of the exposome is growing," says Anthony Macherone, Ph.D., senior applications chemist at Agilent Technologies, and visiting scientist at the Johns Hopkins School of Medicine. ...
    5-1-2013
  • The Tumor Microenvironment as a Drug Target: Chasing Slippery...
    ... investigators at the department of pharmacology and molecular sciences, Johns Hopkins University, say that FAP's pathophysiological role in carcinogenesis may be "highly ...
    5-1-2013
  • Detecting Acquired Drug Resistance in Cancer
    ... The blood analysis was performed using Inostics' BEAMing digital PCR technology. Originally developed in the laboratory of Bert Vogelstein, M.D., at Johns Hopkins, BEAMing ...
    4-29-2013
  • GEN | Biolinks
    ... Jazz Pharmaceuticals, Inc JDJ Bioservices Pty Ltd JDP Therapeutics Inc Johns Hopkins University Johnson & Johnson Johnson & Johnson Corporate Office of Science & ...
  • Merck Sells COMT Inhibitor Rights to Cerecor
    The DAAO inhibitors (D-Amino Acid Oxidase inhibitors) mentioned were more than likely first developed at the Johns Hopkins Brain Science Institute; just this past December, Cerecor ...
    3-20-2013
  • Can Fat Fight Brain Cancer?
    patient's own fat may have the potential to deliver new treatments directly into the brain after the surgical removal of a glioblastoma, according to researchers at Johns Hopkins. ...
    3-12-2013
  • A Windfall for Rock Star Researchers
    ... For cancer genes and targeted therapy Bert Vogelstein, director of the Ludwig Center and Clayton professor of oncology and pathology at the Johns Hopkins Sidney Kimmel ...
    2-21-2013
  • Ten Predictions that Will Transform Healthcare
    ... As biopharmas grow their appetite for cutting R&D costs, telemonitoring can be expected to see much wider clinical use. Written in Blood Researchers at Johns Hopkins Kimmel Cancer ...
    2-15-2013
  • Unlocking Biomarkers' Full Potential
    ... Chan holds the titles of professor in pathology, oncology, radiology, and urology, and is the director of the clinical chemistry division lab at Johns Hopkins Hospital. Given his ...
    2-1-2013
  • Pancreatic Cancer Research Gets $25M Boost
    The new grants will support important research advancements at 18 scientific and medical institutions, including Johns Hopkins University School of Medicine, The David H. Koch ...
    1-23-2013
  • Short-Circuiting HIV Replication
    James Stivers, Ph.D., a professor of pharmacology and molecular sciences at the Johns Hopkins University School of Medicine's Institute for Basic Biomedical Sciences, and ...
    1-18-2013
  • More »

    Journal Articles

  • Palliative Care Online: A Pilot Study on a Pancreatic Cancer...
    Marian S. Grant, Debra L. Wiegand
    Journal of Palliative Medicine
    Design: Descriptive study. Results: The PCNP webpage was added to the Johns Hopkins Pancreatic Cancer Center's website and was visited 707 times by 395 unique computer addresses/...
  • Development of a Claims-Based Risk Score to Identify Obese Individuals
    Jeanne M. Clark, Hsien–Yen Chang, Shari D. Bolen, Andrew D. Shore, Suzanne M. Goodwin, Jonathan P. Weiner
    Population Health Management
    The final sample of 71,057 enrollees was randomly split into 2 subsamples for development and validation of the obesity risk model. Using the Johns Hopkins Adjusted Clinical Groups ...
  • A Physician's Guide to Pain and Symptom Management in Cancer...
    Charles F. von Gunten, Gary Hsin
    Journal of Palliative Medicine
    By Janet Abrahm , M.D. Baltimore and London: The Johns Hopkins University Press, 2005 , 489 pages (paperback), $24.95. Palliative Medicine: A Case-Based Manual, 2nd edition . ...
  • Introduction; The Case Against Assisted Suicide: For the Right...
    Martin L. Smith, Glen Komatsu, Janet Abrahm
    Journal of Palliative Medicine
    Edited by Kathleen Foley and Herbert Hendin . Baltimore: The Johns Hopkins Press, 2002 , 371 pp., $51.00. Physician-Assisted Dying: The Case for Palliative Care and Patient Choice. ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll